NeoDynamics: Comments on the Q2 report
Research Note
2020-08-21
10:14
Redeye gives a brief comment on the Q2 report of NeoDynamics who continue their preparations for the commercialization in selected clinics during the year.
OB
Oscar Bergman
Disclosures and disclaimers